News & Updates

Early (eTRE) and late time-restricted eating (lTRE) both result in significantly reduced intrahepatic fat and improved body composition, liver function, and metabolic health among patients with nonalcoholic fatty liver disease (NAFLD), reports a study.

Treatment with low-dose semaglutide helps reduce the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with HIV, according to data from the single-arm phase IIb ACTG A5371 trial.

In highly viraemic pregnant women with chronic hepatitis B (CHB), stopping peripartum prophylaxis (PP) with tenofovir disoproxil fumarate (TDF) immediately after delivery does not increase the risk of relapse or retreatment vs TDF cessation at ≥4 weeks postpartum. Early withdrawal of PP-TDF, combined with standard neonatal immunization schemes, is 100 percent effective in preventing mother-to-child transmission (MTCT).

Patients with hepatitis B virus (HBV) infection are at heightened risk of latent tuberculosis (TB), while those with latent TB are also at increased risk of HBV infection, reveals a study. Notably, the risk of co-infection is highest among Asians and those born in high-incidence countries.

In the TANGO* trial, a Mediterranean-like, culturally contextualized Asian diet rich in fibre and unsaturated fatty acids, induced multiple health benefits in Chinese women with nonalcoholic fatty liver disease (NAFLD), including weight loss.

Individuals with nonalcoholic fatty liver disease (NAFLD) may face stigma from the disease or comorbidities, but the perceptions of shame differ across patients, healthcare providers, geographic locations, and subspecialties, reveals a study.